Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of FKBP8 mRNA | affects expression | 21346803
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in increased expression of FKBP8 mRNA | increases expression | 15982314
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of FKBP8 mRNA | decreases expression | 15336504
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of FKBP8 mRNA | increases expression | 16404146
|
D015741 |
Metribolone |
Metribolone results in decreased expression of FKBP8 protein | decreases expression | 17152098
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of FKBP8 mRNA | decreases expression | 15982314
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of FKBP8 mRNA | affects expression | 17440010
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of FKBP8 mRNA | decreases expression | 15982314
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of FKBP8 mRNA | affects expression | 21346803
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
16.33 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
16.33 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
16.33 | 7525203 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
5.18 | 18769834 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.60 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.80 | 18769834 16185265 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.61 | 17418594 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.78 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.78 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.19 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.81 | 16206674 16197459 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.02 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.00 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.30 | 15136595 11325840 19526202 15939500 18628466 18234424 16115903 16595493 15668708 17983394 16096432 17369602 17426702 16826403 16935488 15994142 18695136 16264153 16322301 15634643 15567936 15993339 18382427 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.30 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.88 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.13 | 16051944 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.48 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.26 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.26 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.24 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
8.03 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
8.03 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
8.03 | 16096774 16051514 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.66 | 16731534 17007740 17308081 15811867 16109756 16612575 17351982 17974986 15476868 16455267 17329180 17382496 16651473 15792986 17131338 16278810 16364871 16952015 16242529 17928571 16269455 17924179 18627295 17519947 15505089 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.00 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
13.20 | 14694615 |
MESH:D002386 |
Cataract |
|
Tretinoin |
13.20 | 17460283 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
13.20 | 15817613 14694615 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.88 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.48 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.74 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.96 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
10.30 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
10.30 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
3.12 | 9879862 18769834 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.12 | 8800419 16925845 14991402 10589399 9224671 17551590 9125849 9664655 9211117 9142499 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
5.18 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
6.81 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.81 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
6.81 | 18551238 21346803 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.82 | 18602426 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.78 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
8.01 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
8.01 | 16569247 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.47 | 18037988 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.73 | 9664655 16938888 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.87 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.77 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.67 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.67 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.29 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.29 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.48 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.99 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.62 | 17875725 18674790 17888722 16707910 16244371 12587719 16879835 16330681 16495754 16144979 14766674 16244372 18006777 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.46 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.11 | 15692506 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
4.49 | 15817613 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.06 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.59 | 18501091 15147373 17606976 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.37 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.83 | 16778211 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.80 | 12150543 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.02 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.11 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.16 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.36 | 16707910 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.86 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.47 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.90 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.28 | 12679006 17361223 17506722 9834237 17368321 19075265 19029980 16788101 17217047 19642359 16766008 19035177 16140955 17649720 15748426 16891316 16331271 17294898 19225113 17712046 16935935 16823087 17301526 17107899 17339181 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.45 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.69 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.69 | 16248980 18397230 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.13 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.07 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
3.07 | 15899809 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.60 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.96 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.83 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.15 | 15458769 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.85 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.47 | 16827129 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.47 | 17237267 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.47 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.68 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.13 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.70 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.08 | 17415656 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.19 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.02 | 15857846 19429709 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
5.05 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.02 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.49 | 16594593 16946489 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.03 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.18 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.02 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.18 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.68 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
7.68 | 17368321 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
10.12 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
10.12 | 14694615 12819281 17852074 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.28 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.40 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.52 | 15976015 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.47 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.47 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
5.17 | 18769834 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.52 | 16868541 18437689 16888761 15897917 15749863 16729912 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.82 | 16636307 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
6.20 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.08 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.48 | 17922066 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.32 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.18 | 15625365 17710206 16767912 17203757 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.48 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.08 | 17846226 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
3.57 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
10.06 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
10.06 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
10.06 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.83 | 17203757 16767912 15625365 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.46 | 15817613 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.84 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.84 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.98 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.34 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.83 | 17653716 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.87 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.93 | 16752155 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.48 | 16364871 17638931 17334414 17678736 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.29 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.15 | 16287080 |